Prostate Cancer Screening in Singapore

Prostate cancer is a common cancer affecting men in Singapore, particularly those over 50. Early detection through regular screening may improve treatment outcomes and quality of life. A prostate cancer screening programme combines established diagnostic methods with risk assessment to detect potential issues before symptoms develop. Understanding your screening options and maintaining regular check-ups with an MOH-accredited urologist can help support your long-term health outcomes.

*Individual results and timelines may vary.*

doctor img
Dr. Nor Azhari Bin Mohd Zam

MBBS (NUS)|MRCS (Edin.)|MMed Surgery (NUS)|FAMS (Urology)

Prostate Cancer Screening Prostate Cancer Screening in Singapore

What is Prostate Cancer Screening?

Prostate cancer screening uses tests to detect potential signs of prostate cancer before symptoms appear. The screening process typically combines blood tests that measure prostate-specific antigen (PSA) levels with physical examinations to assess prostate health. Unlike diagnostic procedures performed when symptoms are present, screening aims to identify abnormalities in men without symptoms who may be at risk.

The prostate gland, located below the bladder and surrounding the urethra, produces fluid that forms part of semen. As men age, various changes can occur in the prostate, including benign enlargement or the development of cancerous cells. Screening can help differentiate between these conditions and identify cases that may require closer monitoring or intervention.

In Singapore, prostate cancer affects many men. Regular prostate cancer screening in Singapore may be considered as part of men’s preventive healthcare, particularly for those with risk factors such as family history or advancing age.

*Individual screening recommendations may vary based on personal health factors and should be discussed with a healthcare professional.*

Who is a Suitable Candidate?

Potential Candidates

Potential Candidates

  • Men aged 50 and above with average risk factors
  • Men aged 45 and above with family history of prostate cancer
  • Men aged 40 and above with multiple first-degree relatives who had prostate cancer
  • Individuals with urinary symptoms such as frequent urination or weak stream
  • Men with elevated PSA levels from previous tests requiring monitoring
  • Those with genetic predispositions or hereditary cancer syndromes
  • Men seeking baseline assessment before age 50 for future comparison
Contraindications

Contraindications

  • Active urinary tract infections that may affect test results
  • Recent prostate procedures or biopsies within the past 6 weeks
  • Recent ejaculation within 48 hours before PSA testing
  • Current antibiotic treatment for prostatitis
  • Severe medical conditions where screening results wouldn’t change management

The decision to undergo prostate cancer screening should be made through informed discussion with your Singapore urologist, considering individual risk factors, life expectancy, and personal preferences. Our experienced urologists provide recommendations based on current medical guidelines and your specific health profile.

Screening Methods & Approaches

  • Prostate-Specific Antigen (PSA) Test

    The PSA blood test measures levels of a protein produced by the prostate gland. Elevated PSA may indicate prostate cancer, benign prostatic hyperplasia, or prostatitis. Serial PSA measurements over time can provide trending information, with PSA velocity and doubling time offering additional diagnostic insights.

  • Digital Rectal Examination (DRE)

    During a DRE, the urologist inserts a gloved, lubricated finger into the rectum to physically examine the prostate’s size, texture, and consistency. This examination can detect nodules, asymmetry, or unusual firmness that may suggest cancer. While momentarily uncomfortable, the procedure takes less than a minute and can provide clinical information that complements PSA results.

  • Advanced Biomarker Tests

    Screening may include additional biomarkers such as free PSA ratio, Prostate Health Index (PHI), or 4Kscore tests. These tests aim to help distinguish between benign conditions and cancer, potentially reducing unnecessary biopsies. The PCA3 urine test and SelectMDx provide molecular-level assessment of cancer risk.

  • Multi-parametric MRI

    For men with concerning PSA levels or examination findings, multi-parametric MRI offers detailed prostate imaging without radiation exposure. This technology creates detailed images showing suspicious areas, helping guide targeted biopsies if needed and monitoring known lesions over time.

Wondering which screening approach might be suitable for you?

Our MOH-accredited urologists can evaluate your risk factors and discuss appropriate screening options.

The Screening Process

Pre-Screening Preparation

Before your screening appointment, avoid ejaculation for 48 hours as this can temporarily elevate PSA levels. Inform your urologist about any medications, particularly finasteride or dutasteride, which can affect PSA readings. Bring previous PSA results if available for comparison. No fasting is required for PSA blood tests, though you should mention any recent urinary infections or prostate procedures.

During the Screening

Your screening begins with a detailed medical history discussion, including family cancer history, urinary symptoms, and overall health status. Blood is drawn for PSA testing, requiring only a small sample from your arm. The DRE follows, performed with you lying on your side or standing and leaning forward. The physical examination takes approximately 5-10 minutes. Your urologist will explain findings after the examination, though PSA results may require 1-2 days for processing.

Post-Screening

After screening, you can resume normal activities. No recovery time is needed for PSA tests or DRE. Your urologist will discuss preliminary findings from the physical examination and explain when PSA results will be available. You’ll receive guidance on follow-up timing based on initial assessment. Any mild discomfort from the DRE may resolve within minutes. Documentation of your screening results becomes part of your medical record for future reference and trending.

Understanding Your Results

First 24-48 Hours

PSA test results typically become available within 1-2 days. You’ll receive a detailed report showing your PSA level, age-specific normal ranges, and any findings from the physical examination. Your urologist will contact you to discuss results and their implications. If results are normal, you’ll receive recommendations for future screening intervals. Elevated or concerning findings will prompt discussion of additional testing options.

First Week

During your follow-up consultation, your urologist will explain your results in context with your risk factors and previous tests if available. For elevated PSA levels, factors such as prostate size, medications, and recent activities are considered. You’ll receive recommendations which may include repeat PSA testing, additional biomarker tests, or imaging studies. Written documentation of your results and recommendations helps ensure clear understanding and continuity of care.

Long-term Monitoring

Based on your initial screening results, a monitoring schedule may be established. Screening frequency may vary based on individual results and risk factors. Your screening history creates a baseline for detecting changes over time. Regular follow-up aims to identify any concerning trends.

*Individual results and monitoring schedules may vary based on personal health factors and clinical assessment.*

Our urologists provide screening interpretation and follow-up plans.

Schedule your consultation to discuss your prostate health status.

Benefits of Prostate Cancer Screening

Regular prostate cancer screening may offer advantages for men’s health management. Early detection, when cancer remains confined to the prostate, can provide multiple treatment options. Early-stage prostate cancers may be managed with active surveillance, which involves close monitoring without immediate treatment. For aggressive cancers, early detection may enable treatment before spread occurs.

Screening can also identify benign conditions causing similar symptoms, allowing appropriate management of enlarged prostates or infections. Normal results may provide reassurance about prostate health. Establishing baseline PSA levels when younger can provide valuable comparison for future tests. Men with family history may benefit from early detection strategies. Regular screening creates opportunities for discussing overall urological health, addressing concerns about urinary function, sexual health, and general wellbeing with your urologist.

*Individual results and timelines may vary.*

Risks & Potential Limitations

Common Considerations

PSA testing may yield false-positive results, causing anxiety and potentially leading to additional tests. False-negative results can occur, as some aggressive cancers produce little PSA. The DRE may cause temporary mild discomfort or embarrassment for some men. Overdiagnosis of slow-growing cancers that might never cause symptoms remains a consideration in screening discussions.

Rare Complications

Anxiety from abnormal results can affect quality of life while awaiting further testing. Very rarely, aggressive DRE in men with severe haemorrhoids may cause minor bleeding. Some men experience vasovagal responses (light-headedness) during blood draws. Repeat PSA tests may show variability, creating uncertainty about true levels.

Our MOH-accredited urologist carefully interprets screening results within your individual context, aiming to minimise unnecessary concern whilst ensuring appropriate follow-up for abnormal findings. Contemporary risk stratification tools help distinguish significant cancers from indolent disease.

*Individual results and responses may vary.*

Prostate Cancer Screening Cost Considerations

Prostate cancer screening costs vary based on the assessment chosen. Basic screening includes PSA testing and DRE, with costs increasing if additional biomarker tests or imaging studies are needed.

Your screening programme may include initial consultation, PSA test, DRE, results interpretation, and follow-up planning. Additional tests such as free PSA ratio, PHI, or MRI are itemised separately when required. Some men choose comprehensive executive health screening packages that include prostate assessment alongside other health markers. Regular screening can provide health information. The clinic provides detailed cost estimates during consultation, helping you understand screening options within your healthcare budget.

Frequently Asked Questions

At what age should I start prostate cancer screening?

Many men may begin screening at age 50. Those with family history of prostate cancer might consider starting at 45, or even 40 if multiple relatives were affected. Your urologist can recommend an appropriate starting age based on your individual risk factors, including ethnicity, family history, and overall health. The decision involves balancing potential benefits against risks of overdiagnosis.

How often should I undergo prostate cancer screening?

Screening frequency may depend on your initial results and risk factors. Men with PSA below 2.5 ng/mL might screen every 2 years, while those with higher levels could screen annually. More frequent monitoring every 3-6 months may be recommended for rising PSA levels or other concerns. Your urologist can help personalise your screening schedule based on trends in your results and evolving risk profile.

What PSA level is considered concerning?

While PSA above 4.0 ng/mL traditionally prompted further investigation, interpretation considers multiple factors including age, prostate size, and PSA velocity. Younger men may warrant investigation at lower levels, while older men might have benign elevation. The rate of PSA rise over time often provides more information than a single reading. Your urologist interprets PSA within your complete clinical context rather than using rigid cutoffs.

Can I have prostate cancer with a normal PSA level?

Yes, some men with normal PSA levels may have prostate cancer, which is why screening includes DRE alongside PSA testing. Some aggressive cancers produce little PSA, making physical examination important. This limitation of PSA testing underscores the value of comprehensive screening rather than relying on a single test. Regular monitoring helps detect changes even when absolute values remain normal.

What happens if my screening results are abnormal?

Abnormal screening results don’t necessarily indicate cancer. Your urologist may recommend additional testing which could include repeat PSA, additional biomarkers, MRI, or ultimately prostate biopsy if warranted. Many men with elevated PSA have benign conditions. The step-wise approach aims to ensure appropriate investigation while avoiding unnecessary procedures. Your urologist can explain each step, ensuring you understand the rationale for recommended tests.

Are there alternatives to PSA screening?

While PSA remains the primary screening blood test, alternatives include newer biomarkers like PHI, 4Kscore, and PCA3. Some men undergo MRI as primary screening, though this isn’t standard practice. Genetic testing may identify high-risk individuals requiring enhanced screening. No single test replaces the combination of PSA and DRE for routine screening. Your urologist can discuss whether alternative or additional tests suit your situation.

Conclusion

Prostate cancer screening is a part of men’s preventive healthcare, particularly for those with risk factors. By combining PSA testing, physical examination, and, when indicated, advanced diagnostics, screening programmes—such as prostate cancer screening in Singapore—may help detect potential concerns early when treatment options are available. Understanding your personal risk factors and maintaining regular screening according to professional recommendations can support long-term prostate health.

*Individual results and screening outcomes may vary.*

Ready to Take the Next Step?

If you’re considering prostate cancer screening or due for your regular check-up, our MOH-accredited urologists can help you understand your risk profile and establish an appropriate screening schedule. With experience in prostate health management, we provide personalised screening strategies tailored to your individual needs.

Dr. Nor Azhari Bin Mohd Zam

Dr. Nor Azhari Bin Mohd Zam

MBBS (NUS)|MRCS (Edin.)|MMed Surgery (NUS)|FAMS (Urology)

With more than 15 years experience as a certified Urologist, Dr Nor Azhari specializes in treating a wide range of kidney, bladder and prostate conditions as well as disorders of the male reproductive organs.

He offers minimally invasive treatment options and provides same-day appointments for convenience.

  • Skilled urologist and kidney stone surgeon.
  • Director of Endourology (Urinary stone service) at Singapore General Hospital – 2016 to 2023.
  • Recognized with the College of Surgeons Gold Medal and Singapore Urological Association Book prize.
  • Minimally invasive treatment options available (non-invasive and endoscopic/key-hole techniques).

Make an Enquiry

For urgent or same day appointment requests, please call our hotline.

    Full Name*

    Email Address*

    Phone Number*

    Your Message*

    For Faster Response, call us!

    +65‎ 6334‎ 1486

    Our Clinic Locations

    Asian Healthcare Specialists (Novena)

    Mount Elizabeth Novena Specialist Centre
    38 Irrawaddy Road
    #08-41 Singapore 329563

    Asian Healthcare Specialists (Alvernia)

    Mount Alvernia Hospital
    820 Thomson Road Medical Centre Block A #05-03 Singapore 574623